Expression specificity of GFAP transgenes

Neurochemical Research

Volumn 29, Issue 11 SPEC. ISS., 2004, Pages 2075-2093

  Su, Mu ^a   Hu, Huimin ^b   Lee, Youngjin ^a   D'Azzo, Alessandra ^b   Messing, Albee ^c   Brenner, Michael ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Astrocyte; GFAP; promoter; transgene

Indexed keywords

CARBOXYPEPTIDASE C; GALACTOSIDASE; GLIAL FIBRILLARY ACIDIC PROTEIN; INTERMEDIATE FILAMENT PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN REGION; CELL ACTIVITY; CONTROLLED STUDY; DNA SEQUENCE; GENE EXPRESSION; GENE INSERTION; GENE INSERTION SEQUENCE; GENE TARGETING; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; TISSUE SPECIFICITY; TRANSGENE;

ADENOSINE DIPHOSPHATE; ANIMALS; GENE EXPRESSION; GLIAL FIBRILLARY ACIDIC PROTEIN; GREEN FLUORESCENT PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; LAC OPERON; MICE; NEURONS; PERFUSION; PROMOTER REGIONS (GENETICS); STEM CELLS; TRANSGENES;

ANIMALIA; INSERTION SEQUENCES; UNIDENTIFIED INSERTION SEQUENCE;

EID: 10844246335     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-004-6881-1     Document Type: Article

References (82)

1. Eng, L. F., Vanderhaeghen, J. J., Bignami, A., and Gerstl, B. 1971. An acidic protein isolated from fibrous astrocytes. Brain Res. 28:351-354.
2. Eng, L. F. and Ghirnikar, R. S. 1994. GFAP and astrogliosis. Brain Pathol. 4:229-237.
3. McLendon, R. E. and Bigner, D. D. 1994. Immunohistochemistry of the glial fibrillary acidic protein: basic and applied considerations. Brain Pathol. 4:221-228.
4. Mucke, L., Oldstone, M. B., Morris, J. C., and Nerenberg, M. I. 1991. Rapid activation of astrocyte-specific expression of GFAP-lacZ transgene by focal injury. New Biol. 3:465-474.
5. Brenner, M., Kisseberth, W. C., Su, Y., Besnard, F., and Messing, A. 1994. GFAP promoter directs astrocyte-specific expression in transgenic mice. J. Neurosci. 14:1030-1037.
6. Brenner, M. and Messing, A. 1996. GFAP Transgenic Mice. Methods 10:351-364.
7. Smith, J. D., Sikes, J., and Levin, J. A. 1998. Human apolipoprotein E allele-specific brain expressing transgenic mice. Neurobiol. Aging 19:407-413.
8. Zhuo, L., Sun, B., Zhang, C. L., Fine, A., Chiu, S. Y., and Messing, A. 1997. Live astrocytes visualized by green fluorescent protein in transgenic mice. Dev. Biol. 187:36-42.
9. Hahn, C. N., del Pilar Martin, M., Zhou, X. Y., Mann, L. W., and d'Azzo, A. 1998. Correction of murine galactosialidosis by bone marrow-derived macrophages overexpressing human protective protein/cathepsin A under control of the colony-stimulating factor-1 receptor promoter. Proc. Natl. Acad. Sci. USA 95:14880-14885.
10. Shindler, K. S., and Rothn, K. A. 1996. Double immunofluorescent staining using two unconjugated primary antisera raised in the same species. J. Histochem. Cytochem. 44:1331-1335.
11. Besnard, F., Brenner, M., Nakatani, Y., Chao, R., Purohit, H. J., and Freese, E. 1991. Multiple interacting sites regulate astrocyte-specific transcription of the human gene for glial fibrillary acidic protein. J. Biol. Chem. 266:18877-18883.
12. Brenner, M. 1994. Structure and transcriptional regulation of the GFAP gene. Brain Pathol. 4:245-257.
13. Nolte, C., Matyash, M., Pivneva, T., Schipke, C. G., Ohlemeyer, C., Hanisch, U. K., Kirchhoff, F., and Kettenmann, H. 2001. Promoter-controlled EGFP-expressing transgenic mice: a tool to visualize astrocytes and astrogliosis in living brain tissue. Glia 33:72-86.
14. Galou, M., Pournin, S., Ensergueix, D., Ridet, J. L., Tchelingerian, J. L., Lossouarn, L., Privat, A., Babinet, C., and Dupouey, P. 1994. Normal and pathological expression of GFAP promoter elements in transgenic mice. Glia 12:281-293.
15. Morimoto, S., Cassell, M. D., Beltz, T. G., Johnson, A. K., Davisson, R. L., and Sigmund, C. D. 2001. Elevated blood pressure in transgenic mice with brain-specific expression of human angiotensinogen driven by the glial fibrillary acidic protein promoter. Circ. Res. 89:365-372.
16. Sun, Y., Wu, S., Bu, G., Onifade, M. K., Patel, S. N., LaDu, M. J., Fagan, A. M., and Holtzman, D. M. 1998. Glial fibrillary acidic protein-apolipoprotein E (apoE) transgenic mice: astrocyte-specific expression and differing biological effects of astrocyte-secreted apoE3 and apoE4 lipoproteins. J. Neurosci. 18:3261-3272.
17. Tesseur, I., Van Dorpe, J., Spittaels, K., Van den Haute, C., Moechars, D., and Van Leuven, F. 2000. Expression of human apolipoprotein E4 in neurons causes hyperphosphorylation of protein tau in the brains of transgenic mice. Am. J. Pathol. 156:951-964.
18. Bennett, J. L., Elhofy, A., Canto, M. C., Tani, M., Ransohoff, R. M., and Karpus, W. J. 2003. CCL2 transgene expression in the central nervous system directs diffuse infiltration of CD45(high)CD11b(+) monocytes and enhanced Theiler's murine encephalomyelitis virus-induced demyelinating disease. J. Neurovirol. 9:623-36.
19. Marino, S., Vooijs, M., van Der Gulden, H., Jonkers, J., and Berns, A. 2000. Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum. Genes Dev. 14:994-1004.
20. Zhuo, L., Theis, M., Alvarez-Maya, I., Brenner, M., Willecke, K., and Messing, A. 2001. hGFAP-cre transgenic mice for manipulation of glial and neuronal function in vivo. Genesis 31:85-94.
21. Bajenaru, M. L., Zhu, Y., Hedrick, N. M., Donahoe, J., Parada, L. F., and Gutmann, D. H. 2002. Astrocyte-specific inactivation of the neurofibromatosis 1 gene (NF1) is insufficient for astrocytoma formation. Mol. Cell Biol. 22:5100-5113.
22. Theis, M., Jauch, R., Zhuo, L., Speidel, D., Wallraff, A., Doring, B., Frisch, C., Sohl, G., Teubner, B., Euwens, C., Huston, J., Steinhauser, C., Messing, A., Heinemann, U., and Willecke, K. 2003. Accelerated hippocampal spreading depression and enhanced locomotory activity in mice with astrocyte-directed inactivation of connexin43. J. Neurosci. 23:766-776.
23. Li, B., Yang, Z., Hou, J., McCracken, A., Jennings, M. A., and Ma, M. Y. 2003. Compromised reproductive function in adult female mice selectively expressing mutant ErbB-1 tyrosine kinase receptors in astroglia. Mol. Endocrinol. 17:2365-2376.
24. Prevot, V., Rio, C., Cho, G. J., Lomniczi, A., Heger, S., Neville, C. M., Rosenthal, N. A., Ojeda, S. R., and Corfas, G. 2003. Normal female sexual development requires neuregulin-erbB receptor signaling in hypothalamic astrocytes. J. Neurosci. 23:230-239.
25. Salhia, B., Angelov, L., Roncari, L., Wu, X., Shannon, P., and Guha, A. 2000. Expression of vascular endothelial growth factor by reactive astrocytes and associated neoangiogenesis. Brain Res. 883:87-97.
26. Peel, A. L. and Klein, R. L. 2000. Adeno-associated virus vectors: activity and applications in the CNS. J. Neurosci. Methods 98:95-104.
27. Kuzmanovic, M., Dudley, V. J., and Sarthy, V. P. 2003. GFAP promoter drives Muller cell-specific expression in transgenic mice. Invest. Ophthalmol. Vis. Sci. 44:3606-3613.
28. Jakobsson, J., Ericson, C., Jansson, M., Bjork, E., and Lundberg, C. 2003. Targeted transgene expression in rat brain using lentiviral vectors. J. Neurosci. Res. 73:876-885.
29. Toggas, S. M., Masliah, E., Rockenstein, E. M., Rall, G. F., Abraham, C. R., and Mucke, L. 1994. Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature 367:188-193.
30. Bohlooly, Y. M., Olsson, B., Gritli-Linde, A., Brusehed, O., Isaksson, O. G., Ohlsson, C., Soderpalm, B., Tornell, J., and Ola, B. 2001. Enhanced Spontaneous Locomotor Activity in Bovine GH Transgenic Mice Involves Peripheral Mechanisms. Endocrinology 142:4560-4567.
31. Cornet, A., Savidge, T. C., Cabarrocas, J., Deng, W. L., Colombel, J. F., Lassmann, H., Desreumaux, P., and Liblau, R. S. 2001. Enterocolitis induced by autoimmune targeting of enteric glial cells: A possible mechanism in Crohn's disease? Proc. Natl. Acad. Sci. USA 98:13306-13311.
32. Pagenstecher, A., Lassmann, S., Carson, M. J., Kincaid, C. L., Stalder, A. K., and Campbell, I. L. 2000. Astrocyte-targeted expression of IL-12 induces active cellular immune responses in the central nervous system and modulates experimental allergic encephalomyelitis. J. Immunol. 164:4481-4492.
33. Johnson, W. B., Ruppe, M. D., Rockenstein, E. M., Price, J., Sarthy, V. P., Verderber, L. C., and Mucke, L. 1995. Indicator expression directed by regulatory sequences of the glial fibrillary acidic protein (GFAP) gene: In vivo comparison of distinct GFAP-lacZ transgenes. Glia 13:174-184.
34. Verderber, L., Johnson, W., Mucke, L., and Sarthy, V. 1995. Differential regulation of a glial fibrillary acidic protein-LacZ transgene in retinal astrocytes and Muller cells. Invest. Ophthalmol. Vis. Sci. 36:1137-1143.
35. Hannas-Djebbara, Z., Didier-Bazs, M., Sacchettoni, S., Prod'hon, C., Jouvet, M., Belin, M. F., and Jacquemont, B. 1997. Transgene expression of plasmid DNAs directed by viral or neural promoters in the rat brain. Brain Res. Mol. Brain Res. 46:91-99.
36. McKie, E. A., Graham, D. I., and Brown, S. M. 1998. Selective astrocytic transgene expression in vitro and in vivo from the GFAP promoter in a HSV RL1 null mutant vector-potential glioblastoma targeting. Gene Ther. 5:440-450.
37. Shi, N., Zhang, Y., Zhu, C., Boado, R. J., and Pardridge, W. M. 2001. Brain-specific expression of an exogenous gene after i.v. administration. Proc. Natl. Acad. Sci. USA 98:12754-12759.
38. Stuve, O., Youssef, S., Slavin, A. J., King, C. L., Patarroyo, J. C., Hirschberg, D. L., Brickey, W. J., Soos, J. M., Piskurich, J. F., Chapman, H. A., and Zamvil, S. S. 2002. The role of the MHC class II transactivator in class II expression and antigen presentation by astrocytes and in susceptibility to central nervous system autoimmune disease. J. Immunol. 169:6720-6732.
39. Jensen, N. A., Pedersen, K. M., Lihme, F., Rask, L., Nielsen, J. V., Rasmussen, T. E., and Mitchelmore, C. 2003. Astroglial c-Myc overexpression predisposes mice to primary malignant gliomas. J. Biol. Chem. 278:8300-8308.
40. Cui, W., Allen, N. D., Skynner, M., Gusterson, B., and Clark, A. J. 2001. Inducible ablation of astrocytes shows that these cells are required for neuronal survival in the adult brain. Glia 34:272-282.
41. Raeber, A. J., Race, R. E., Brandner, S., Priola, S. A., Sailer, A., Bessen, R. A., Mucke, L., Manson, J., Aguzzi, A., Oldstone, M. B., Weissmann, C., and Chesebro, B. 1997. Astrocyte-specific expression of hamster prion protein (PrP) renders PrP knockout mice susceptible to hamster scrapie. EMBO J. 16:6057-6065.
42. Ding, H., Roncari, L., Shannon, P., Wu, X., Lau, N., Karaskova, J., Gutmann, D. H., Squire, J. A., Nagy, A., and Guha, A. 2001. Astrocyte-specific expression of activated p21-ras results in malignant astrocytoma formation in a transgenic mouse model of human gliomas. Cancer Res. 61:3826-3836.
43. Morimoto, S., Cassell, M. D., and Sigmund, C. D. 2002. Glia- and neuron-specific expression of the renin-angiotensin system in brain alters blood pressure, water intake, and salt preference. J. Biol. Chem. 277:33235-33241.
44. Gong, Y. H., Parsadanian, A. S., Andreeva, A., Snider, W. D., and Elliott, J. L. 2000. Restricted expression of G86R Cu/Zn superoxide dismutase in astrocytes results in astrocytosis but does not cause motoneuron degeneration. J. Neurosci. 20:660-665.
45. Weissenberger, J., Steinbach, J. P., Malin, G., Spada, S., Rulicke, T., and Aguzzi, A. 1997. Development and malignant progression of astrocytomas in GFAP-v-src transgenic mice. Oncogene 14:2005-2013.
46. Xiao, A., Wu, H., Pandolfi, P. P., Louis, D. N., and Van Dyke, T. 2002. Astrocyte inactivation of the pRb pathway predisposes mice to malignant astrocytoma development that is accelerated by PTEN mutation. Cancer Cell 1:157-168.
47. Wyss-Coray, T., Feng, L., Masliah, E., Ruppe, M. D., Lee, H. S., Toggas, S. M., Rockenstein, E. M., and Mucke, L. 1995. Increased central nervous system production of extracellular matrix components and development of hydrocephalus in transgenic mice overexpressing transforming growth factor-beta 1. Am. J. Pathol. 147:53-67.
48. Delaney, C. L., Brenner, M., and Messing, A. 1996. Conditional ablation of cerebellar astrocytes in postnatal transgenic mice. J. Neurosci. 16:6908-6918.
49. Morshead, C. M., Garcia, A. D., Sofroniew, M. V., and van Der Kooy, D. 2003. The ablation of glial fibrillary acidic protein-positive cells from the adult central nervous system results in the loss of forebrain neural stem cells but not retinal stem cells. Eur. J. Neurosci. 18:76-84.
50. Imura, T., Kornblum, H. I., and Sofroniew, M. V. 2003. The predominant neural stem cell isolated from postnatal and adult forebrain but not early embryonic forebrain expresses GFAP. J. Neurosci. 23:2824-2832.
51. Ralph, G. S., Bienemann, A., Harding, T. C., Hopton, M., Henley, J., and Uney, J. B. 2000. Targeting of tetracycline-regulatable transgene expression specifically to neuronal and glial cell populations using adenoviral vectors. Neuroreport 11:2051-2055.
52. Segovia, J., Vergara, P., and Brenner, M. 1998. Astrocyte-specific expression of tyrosine hydroxylase after intracerebral gene transfer induces behavioral recovery in experimental parkinsonism. Gene Ther. 5:1650-1655.
53. Zhang, Y., Schlachetzki, F., Zhang, Y. F., Boado, R. J., and Pardridge, W. M. 2004. Normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism with intravenous nonviral gene therapy and a brain-specific promoter. Hum. Gene Ther. 15:339-350.
54. Sarthy, P. V. and Fu, M. 1989. Transcriptional activation of an intermediate filament protein gene in mice with retinal dystrophy. DNA 8:437-446.
55. Bush, T. G., Puvanachandra, N., Horner, C. H., Polito, A., Ostenfeld, T., Svendsen, C. N., Mucke, L., Johnson, M. H., and Sofroniew, M. V. 1999. Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice. Neuron 23:297-308.
56. Dobie, K. W., Lee, M., Fantes, J. A., Graham, E., Clark, A. J., Springbett, A., Lathe, R., and McClenaghan, M. 1996. Variegated transgene expression in mouse mammary gland is determined by the transgene integration locus. Proc. Natl. Acad. Sci. USA 93:6659-6664.
57. Jessen, K. R., Thorpe, R., and Mirsky, R. 1984. Molecular identity, distribution and heterogeneity of glial fibrillary acidic protein: an immunoblotting and immunohistochemical study of Schwann cells, satellite cells, enteric glia and astrocytes. J. Neurocytol. 13:187-200.
58. Hatfield, J. S., Skoff, R. P., Maisel, H., and Eng, L. 1984. Glial fibrillary acidic protein is localized in the lens epithelium. J. Cell Biol. 98:1895-1898.
59. Hainfellner, J. A., Voigtlander, T., Strobel, T., Mazal, P. R., Maddalena, A. S., Aguzzi, A., and Budka, H. 2001. Fibroblasts can express glial fibrillary acidic protein (GFAP) in vivo. J. Neuropathol. Exp. Neurol. 60:449-461.
60. Gard, A. L., White, F. P., and Dutton, G. R. 1985. Extraneural glial fibrillary acidic protein (GFAP) immunoreactivity in perisinusoidal stellate cells of rat liver. J. Neuroimmunol. 8:359-375.
61. Holash, J. A., Harik, S. I., Perry, G., and Stewart, P. A. 1993. Barrier properties of testis microvessels. Proc. Natl. Acad. Sci. USA 90:11069-11073.
62. Rio, C., Dikkes, P., Liberman, M. C., and Corfas, G. 2002. Glial fibrillary acidic protein expression and promoter activity in the inner ear of developing and adult mice. J. Comp. Neurol. 442:156-162.
63. Viale, G., Gambacorta, M., Coggi, G., Dell'Orto, P., Milani, M., and Doglioni, C. 1991. Glial fibrillary acidic protein immunoreactivity in normal and diseased human breast. Virchows Arch. A Pathol. Anat. Histopathol. 418:339-348.
64. Viale, G., Doglioni, C., Dell'Orto, P., Zanetti, G., Iuzzolino, P., Bontempini, L., and Coggi, G. 1988. Glial fibrillary acidic protein immunoreactivity in human respiratory tract cartilages and pulmonary chondromatous hamartomas. Am. J. Pathol. 133:363-373.
65. Riol, H., Tardy, M., Rolland, B., Levesque, G., and Murthy, M. R. 1997. Detection of the peripheral nervous system (PNS)-type glial fibrillary acidic protein (GFAP) and its mRNA in human lymphocytes. J. Neurosci. Res. 48:53-62.
66. Schinke, M., Baltatu, O., Bohm, M., Peters, J., Rascher, W., Bricca, G., Lippoldt, A., Ganten, D., and Bader, M. 1999. Blood pressure reduction and diabetes insipidus in transgenic rats deficient in brain angiotensinogen. Proc. Natl. Acad. Sci. USA 96:3975-3980.
67. Lochard, N., Silversides, D. W., van Kats, J. P., Mercure, C., and Reudelhuber, T. L. 2003. Brain-specific restoration of angiotensin II corrects renal defects seen in angiotensinogen-deficient mice. J. Biol. Chem. 278:2184-2189.
68. Guo, H., Lai, L., Butchbach, M. E., Stockinger, M. P., Shan, X., Bishop, G. A., and Lin, C. L. 2003. Increased expression of the glial glutamate transporter EAAT2 modulates excitotoxicity and delays the onset but not the outcome of ALS in mice. Hum. Mol. Genet. 12:2519-2532.
69. Chen, S., Rio, C., Ji, R. R., Dikkes, P., Coggeshall, R. E., Woolf, C. J., and Corfas, G. 2003. Disruption of ErbB receptor signaling in adult non-myelinating Schwann cells causes progressive sensory loss. Nat. Neurosci. 6:1186-1193.
70. Cabarrocas, J., Piaggio, E., Zappulla, J. P., Desbois, S., Mars, L. T., Lassmann, H., and Liblau, R. S. 2004. A transgenic mouse model for T-cell ignorance of a glial autoantigen. J. Autoimmun. 22:179-189.
71. Akwa, Y., Hassett, D. E., Eloranta, M. L., Sandberg, K., Masliah, E., Powell, H., Whitton, J. L., Bloom, F. E., and Campbell, I. L. 1998. Transgenic expression of IFN-alpha in the central nervous system of mice protects against lethal neurotropic viral infection but induces inflammation and neurodegeneration. J. Immunol. 161:5016-5026.
72. LaFerla, F. M., Sugarman, M. C., Lane, T. E., and Leissring, M. A. 2000. Regional hypomyelination and dysplasia in transgenic mice with astrocyte-directed expression of interferon-gamma. J. Mol. Neurosci. 15:45-59.
73. Campbell, I. L., Abraham, C. R., Masliah, E., Kemper, P., Inglis, J. D., Oldstone, M. B., and Mucke, L. 1993. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc. Natl. Acad. Sci. USA 90:10061-10065.
74. Huang, D., Tani, M., Wang, J., Han, Y., He, T. T., Weaver, J., Charo, I. F., Tuohy, V. K., Rollins, B. J., and Ransohoff, R. M. 2002. Pertussis toxin-induced reversible encephalopathy dependent on monocyte chemoattractant protein-1 overexpression in mice. J. Neurosci. 22:10633-10642.
75. Rall, G. F., Mucke, L., Nerenberg, M., and Oldstone, M. B. 1994. A transgenic mouse model to assess the interaction of cytotoxic T lymphocytes with virally infected, class I MHC-expressing astrocytes. J. Neuroimmunol. 52:61-68.
76. Barton, M. D., Dunlop, J. W., Psaltis, G., Kulik, J., DeGennaro, L., and Kwak, S. P. 2002. Modified GFAP promoter auto-regulates tet-activator expression for increased transactivation and reduced tTA-associated toxicity. Brain Res. Mol. Brain Res. 101:71-81.
77. Bush, T. G., Savidge, T. C., Freeman, T. C., Cox, H. J., Campbell, E. A., Mucke, L., Johnson, M. H., and Sofroniew, M. V. 1998. Fulminant jejuno-ileitis following ablation of enteric glia in adult transgenic mice. Cell 93:189-201.
78. Sofroniew, M. V., Bush, T. G., Blumauer, N., Kruger, L., Mucke, L., and Johnson, M. H. 1999. Genetically-targeted and conditionally-regulated ablation of astroglial cells in the central, enteric and peripheral nervous systems in adult transgenic mice. Brain Res. 835:91-95.
79. Gregerson, D. S., and Dou, C. 2002. Spontaneous induction of immunoregulation by an endogenous retinal antigen. Invest. Ophthalmol. Vis. Sci. 43:2984-2991.
80. Malatesta, P., Hack, M. S., Hartfuss, E., Kettenmann, H., Klinkert, W., Kirchhoff, F., and Götz, M. 2003. Neuronal or glial progeny: regional differences in radial glia fate. Neuron 37:751-764.
81. Anthony, T. E., Klein, C., Fishell, G., and Heintz, N. 2004. Radial glia serve as neuronal progenitors in all regions of the central nervous system. Neuron 41:881-890.
82. Doetsch, F. 2003. The glial identity of neural stem cells. Nat. Neurosci. 6:1127-1134.